Disclosures for "Psychometric Validation of a Modified United Multiple System Atrophy Rating Scale ")
-
Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Potashman has received personal compensation for serving as an employee of Biogen.
-
Ms. Brady has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. Brady has stock in Biohaven Pharmaceuticals.
-
Susan Durham has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Susan Durham has received stock or an ownership interest from Biohaven Pharmaceuticals.
-
Victoria Wirtz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Victoria Wirtz has received stock or an ownership interest from Biohaven Pharmaceuticals, Inc.
-
Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has received stock or an ownership interest from biohaven pharmaceuticals.
-
Vlad Coric has received personal compensation for serving as an employee of Biohaven. Vlad Coric has received stock or an ownership interest from Biohaven. Vlad Coric has received intellectual property interests from a discovery or technology relating to health care.
-
Günter Hoglinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Günter Hoglinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Günter Hoglinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Günter Hoglinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Günter Hoglinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Günter Hoglinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Aventis. Günter Hoglinger has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Günter Hoglinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Günter Hoglinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Günter Hoglinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Günter Hoglinger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Günter Hoglinger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme.
-
Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
-
Dr. Low has nothing to disclose.
-
The institution of Dr. McFarland has received research support from NIH.
-
Wassilios Meissner has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alterity. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Wassilios Meissner has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Wassilios Meissner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
-
The institution of Patricio Millar Vernetti has received research support from NIH. The institution of Patricio Millar Vernetti has received research support from Theravance. Patricio Millar Vernetti has received personal compensation in the range of $500-$4,999 for serving as a Speaker with WPC.
-
Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
-
Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
-
Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO . Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Seppi has received research support from MJFF. The institution of Dr. Seppi has received research support from EU. The institution of Dr. Seppi has received research support from FWF Austrian Science Fund,.
-
Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Icon PLC. The institution of Dr. Singer has received research support from NIH. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LabCorp. The institution of Dr. Vernino has received research support from Grifols. The institution of Dr. Vernino has received research support from Dysautonomia International. The institution of Dr. Vernino has received research support from BioHaven.
-
Dr. Qureshi has received personal compensation for serving as an employee of Biohaven.